Workday & the Reckoning — Faircurve Equity Pulse · 23 May 2026

Workday closed Friday at $128 — down 46% YoY and roughly half of last October's $257 peak — after a year in which the market priced in agentic-AI seat cannibalisation, a softer Federal pipeline, and a deferred margin glide-path. Then Thursday night's Q1 FY27 print delivered a +5% relief rally: best Q1 new-ACV growth in five years, FY27 op-margin guide raised 50 bps to 30.5%, and agentic AI ARR now +200% YoY on roughly $500M. We initiate at BUY · $162 on a consensus-anchored blend that trades a 12.1x forward P/E for an enterprise franchise refounding under returned-CEO Aneel Bhusri. Upside +26%; downside to ~$104 if the agent thesis breaks.

By Faircurve Research

Workday & the Reckoning

Faircurve Equity Pulse · Single-Name Research

NASDAQ : WDAY 23 May 2026
SPOT $128.14 (+5.2%)
BUY · $162

Workday closed Friday at $128 — down 46% YoY and roughly half of last October's $257 peak — after a year in which the market priced in agentic-AI seat cannibalisation, a softer Federal pipeline, and a deferred margin glide-path. Then Thursday night's Q1 FY27 print delivered a +5% relief rally: best Q1 new-ACV growth in five years, FY27 op-margin guide raised 50 bps to 30.5%, and agentic AI ARR now +200% YoY on roughly $500M. We initiate at BUY · $162 on a consensus-anchored blend that trades a 12.1x forward P/E for an enterprise franchise refounding under returned-CEO Aneel Bhusri. Upside +26%; downside to ~$104 if the agent thesis breaks.

§ 01 — Tape & Setup

The Snapshot

PRICE

$128.14

+5.2% Fri

MARKET CAP

$34.0B

-46.2% YoY

12M TARGET

$162

+26% upside

RATING

BUY

Faircurve

FWD P/E (FY27)

12.1x

vs peers 15.9x

FWD EV/EBITDA

13.4x

vs peers 10.4x

FCF YIELD TTM

8.8%

$2.78B FY26 FCF

BUYBACKS FY26

$2.9B

8.5% of cap

WDAYWorkday, Inc.1-YEAR PRICE HISTORY$128.14$100$200$30052W HIGH $257.092025-10-2352W LOW $110.362026-04-09May 25Jul 25Oct 25Jan 26Apr 26SPOTPRICE50DMA200DMA1Y RETURN-46.2%MAX DRAWDOWN-55.5%30D VOL (ANN.)59.9%BETA (5Y)1.04

§ 02 — Thesis · Bull vs Bear

The Debate at $128

Cheapest forward multiple in a decade

12.1x FY27 non-GAAP P/E vs WDAY's 5-yr median ~32x and current peer median 15.9x. Most of the seat-cannibalisation tail risk is now in the price.

Q1 FY27 confirmed franchise intact

Subscription rev $2.35B (+14% YoY); cRPO $8.81B (+15.5%); FCF $616M (+46%); Aneel called it 'best Q1 new-ACV growth in 5 years'. Most slipped Q4 deals closed.

Agent System of Record gaining traction

Agentic ARR ~$500M (+200% YoY); customers are buying Workday-built agents rather than internal or start-up alternatives. AI is incremental, not cannibalisation, so far.

Capital return is intact

FY26 buybacks $2.9B (8.5% of float); $1B re-authorisation in Q4 FY25; FCF margin 29% with revenue still compounding double-digits. The repricing is multiple, not cash.

Sub-rev growth has slowed to ~14%

From 17% in Q2 FY25 to 13-14% range now. FY27 guide of $9.93-9.95B is +12-13%, the lowest growth Workday has ever guided. Multiple compression follows growth compression.

Agent monetisation is unproven

Flex Credits consumption pricing is brand new; $500M agentic ARR is mostly Sana + Paradox + early-attach. Real organic agent revenue is still ahead — execution risk is real.

Fed/SLED/healthcare cycle elongation

Rob Enslin explicitly flagged in Q4 FY26 that large-enterprise deals are taking longer in Federal, SLED, healthcare and parts of commercial — the macro 'new norm.'

Margin-vs-growth tradeoff

Aneel's return de-prioritised the prior 35% FY28 op-margin target in favor of AI investment. FY27 30.5% is below where the prior management team had guided.

Our Read

The de-rating is real and largely deserved — Workday's growth has decelerated and the AI transition introduces genuine product risk. But at 12x forward P/E and a $34B market cap on $2.8B of FCF, the market is now pricing Workday as a mature payroll vendor. Q1 FY27 was the first quarter that argued back: franchise stable, ACV reaccelerating, agentic ARR ramping fast. We frame this as a refounding trade, not a broken thesis trade. Aneel back, Hellermark running AI, Sana in the platform, Flex Credits monetising consumption — the pieces are in place. The market wants proof. Q2 FY27 print and FY28 prelim are the next gates.

Three Things to Watch

One — Agentic ARR run-rate: management hasn't disclosed organic-only agent revenue. If they break it out at the Sep analyst day, watch for >$200M annualised. Two — Q2 FY27 cRPO: needs to hold +15% to confirm Q1 wasn't a one-quarter pull-forward. Three — FY28 prelim guide at the Q4 print: anything above +13% sub-rev growth signals that AI is contributing to bookings rather than just compressing seat counts.

§ 03 — The Latest Print

Q1 FY27 — the relief, in numbers

Workday's Q1 FY27 print, delivered Thursday after the close, was the firmest data the bulls have had in 18 months. Subscription revenue $2.35B (+14% YoY), total revenue $2.54B (+13%), non-GAAP op margin 31.8%, and free cash flow $616M (+46%) — all above the Street. Aneel Bhusri, two quarters back in the CEO seat after Carl Eschenbach's exit, called it the 'best first quarter of new ACV growth in five years' and explicitly noted that most of the large enterprise deals that slipped in Q4 closed in Q1. Management raised the FY27 non-GAAP op-margin guide by 50 bps to 30.5% and reiterated subscription revenue of $9.925-9.95B (+12-13%). The market rewarded the print with a +5.2% gap up on Friday, the strongest single-day move in nine months.

Operational dashboard, Q1 FY27

Metric	Q1 FY27	Q4 FY26	Q1 FY26	YoY
Total revenue	$2,542M	$2,532M	$2,240M	+13.5%
Subscription revenue	$2,354M	$2,360M	$2,059M	+14.3%
12M cRPO	$8.81B	$8.83B	$7.63B	+15.5%
Total backlog	$27.29B	$28.1B	$24.62B	+10.8%
Non-GAAP op margin	31.8%	30.6%	30.2%	+160 bps
Free cash flow	$616M	$1,220M	$423M	+46%
Diluted EPS (GAAP)	$0.87	$0.55	$0.25	+248%

§ 04 — Five-Year Trends

Decade in fast forward

($M unless noted)	FY22	FY23	FY24	FY25	FY26
Revenue	5,139	6,216	7,259	8,446	9,552
YoY growth	+19%	+21%	+17%	+16%	+13%
Gross profit	3,711	4,506	5,488	6,377	7,231
GM %	72.2%	72.5%	75.6%	75.5%	75.7%
EBITDA	377	206	752	1,078	1,356
EBITDA margin	7.3%	3.3%	10.4%	12.8%	14.2%
GAAP op income	(116)	(222)	183	415	1,024
GAAP net income	29	(367)	1,381*	526	693
Diluted EPS	$0.12	$(1.44)	$5.21*	$1.95	$2.58
Operating cash flow	1,651	1,657	2,149	2,461	2,939
Free cash flow	1,378	1,297	1,911	2,189	2,777
FCF margin	26.8%	20.9%	26.3%	25.9%	29.1%
Buybacks ($M)	—	75	423	700	2,895
Net debt	568	1,363	1,284	1,819	2,320

The five-year picture is the Workday paradox in one table. Revenue compounded 17% annually from $5.1B in FY22 to $9.6B in FY26. Free cash flow more than doubled to $2.78B and FCF margin expanded from 27% to 29%. Yet GAAP EPS is volatile because FY24 carried a $1.06B deferred-tax benefit (the asterisked row) that exaggerated that year's net income — strip it out and the trend is steady FY24 ~$320M → FY25 $526M → FY26 $693M. Buybacks scaled from zero to $2.9B in FY26, now ~8.5% of float annually. The franchise is not broken. What's broken is the multiple: EV/EBITDA fell from a high-20s historical median to 13x today.

§ 05 — Earnings Call Signal

Eight quarters, in numbers

Theme mention frequency across 8 quarters

Theme	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
AI / Agents	22	38	55	48	62	88	95	102
Illuminate	0	4	3	3	4	4	1	0
Strategic Sourcing (Sana)	0	0	0	0	0	6	14	11
Public Sector / Federal	4	9	11	10	14	16	12	14
Financial Management / Fins	13	14	18	17	12	9	6	4
International / EMEA	16	15	18	15	18	19	12	14
Backlog / cRPO	9	8	8	8	11	10	9	6
Headcount / Op Discipline	3	2	11	5	4	3	6	8
Partner Ecosystem	21	18	22	20	18	16	12	11

Recurring metrics quoted in prepared remarks

Metric	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Total revenue ($M)	2,085	2,160	2,210	2,240	2,348	2,432	2,532	2,542
Sub revenue ($M)	1,903	1,959	2,040	2,059	2,169	2,244	2,360	2,354
Sub rev growth YoY	+17%	+16%	+16%	+13%	+14%	+15%	+16%	+14%
12M cRPO	$6.80B	$6.98B	$7.63B	$7.63B	$7.91B	$8.21B	$8.83B	$8.81B
Total backlog	$21.6B	$22.2B	$25.1B	$24.6B	$25.4B	$26.0B	$28.1B	$27.3B
Non-GAAP op margin	24.9%	26.3%	26.4%	30.2%	29.0%	28.5%	30.6%	31.8%
OCF (qtr)	$571M	$406M	$1,110M	$457M	$616M	$588M	$1,280M	$696M

Reading the arc

Across eight quarters the language has shifted from AI/Illuminate (Q2-Q4 FY25) to Agent System of Record + role-based agents (Q4 FY25 launch) to agentic AI + Flex Credits consumption (Q4 FY26 → Q1 FY27); agentic ARR scaled from ~30% expansion attach in Q3 FY25 to +200% YoY (~$500M) by Q1 FY27. Carl-era management framed macro as 'the new norm' from Q2 FY25; Q4 FY26 was peak panic — Rob's explicit Fed/SLED/healthcare admission — and Q1 FY27 the relief, with Aneel back, Joel Hellermark (Sana) as Chief AI Officer, and most slipped Q4 deals closed. The op-margin guide quietly traded the prior 35% FY28 target for AI investment — Workday is now a growth-reacceleration story, not a margin-expansion story.

§ 06 — Earnings Call Signal · Voices

Guidance cadence + three quotes

Q on call	FY sub-rev guide	FY op-margin guide	Framing
Q2 FY25	FY25 $7.70B (+17%)	FY25 25.25%	REITERATED; lowered medium-term
Q3 FY25	FY25 $7.70B (+17%)	FY25 25.5%	REITERATED + raised margin
Q4 FY25	FY26 ~$8.8B (+14%)	FY26 ~28%	INTRODUCED FY26; new $1B buyback
Q1 FY26	FY26 ~$8.8B (+14%)	FY26 ~28.5%	REITERATED + raised margin 50bps
Q2 FY26	FY26 $8.82B (+14%)	FY26 ~29%	RAISED on Paradox; raised margin
Q3 FY26	FY26 $8.83B (+14%)	FY26 ~29%	Narrow RAISE for Sana
Q4 FY26	FY27 $9.93B (+12-13%)	FY27 ~30%	INTRODUCED FY27 below prior plan
Q1 FY27	FY27 $9.93B (+12-13%)	FY27 30.5%	REITERATED + RAISED margin 50bps

Verbatim quotes — the narrative arc

Aneel Bhusri · CEO (returned) · Q1 FY27 · 21 May 2026 · FUTURE-VISION

“I have even more conviction that this is Workday's moment to lead. Not one of them is looking to replace Workday with something they're building internally or from a start-up. Instead, they were looking to us first for AI solutions for the HR and finance worlds, and hopefully, IT in the future. It's really our opportunity for the taking, but we need to execute flawlessly and with speed.”

Rob Enslin · President & CCO · Q4 FY26 · 24 Feb 2026 · CANDID-DOWNSIDE

“Some net new large enterprise deals are taking longer to close, particularly in Fed, SLED and health care and across parts of the commercial market. While this impacted the volume of net new deals that closed in Q4, most opportunities remain active in our pipeline and a few have already closed in Q1.”

Aneel Bhusri · CEO (returned) · Q4 FY26 · 24 Feb 2026 · CONDITIONAL-BULL

“If FY '26 proved that customers trusted Workday to buy our acquired agents, we believe that FY '27 and beyond will prove that customers will buy our organically built agents that are in early access today. Across the board, these new agents are deeply embedded into the Workday core, are meaningful in their scope and have significant ROI attached to each and every one of them.”

§ 07 — Peer Set · Forward Multiples

Where it trades vs the cluster

Faircurve-curated peer set. ADP anchors the mature HCM franchise; Paycom the cloud-HCM growth comp; Salesforce the front-office SaaS comparable also working through a de-rating; ServiceNow the enterprise-workflow platform still trading on growth. Each anchors a different narrative engine that Workday is now trading inside. All forward multiples use each peer's next-fiscal-year (FY+1) consensus from FMP analyst estimates, pulled 2026-05-23. Anchor years: WDAY FY27 (Jan'27), ADP FY27 (Jun'27), PAYC FY27 (Dec'27), CRM FY27 (Jan'27), NOW FY27 (Dec'27).

Forward P/E (FY+1) — sorted high to low

NOW

20.2x

ADP

18.5x

Peer avg

15.9x

CRM

13.6x

WDAY

12.1x

PAYC

11.2x

Full peer table — all forward FY+1 multiples

Ticker	Mkt cap	Fwd P/E	Fwd EV/EBITDA	Fwd P/S	Fwd EBITDA mgn	Fwd rev gr
ADP	$90.1B	18.5x	10.9x	3.89x	35.9%	+5.8%
PAYC	$7.5B	11.2x	7.0x	3.21x	49.3%	+7.1%
CRM	$171.1B	13.6x	8.0x	3.71x	49.3%	+11.1%
NOW	$105.3B	20.2x	15.5x	5.49x	35.4%	+18.5%
Peer avg	—	15.9x	10.4x	4.08x	42.5%	+10.6%
WDAY	$34.0B	12.1x	13.4x	3.19x	24.6%	+11.6%

Competitive position read

Workday at 12.1x forward P/E is now the cheapest growth name in the cluster, trading below PAYC (smaller, more EPS-sensitive) and well below ADP (slower-growing but with a structural payroll-float earnings stream). On EV/EBITDA the comparison flips — WDAY at 13.4x sits above CRM/PAYC/ADP because GAAP EBITDA absorbs Workday's $1.6B annual SBC; on Workday's own historical multiple (5-yr median ~22x EV/EBITDA and ~32x P/E), today is two standard deviations cheap. The de-rated cluster reflects the market's view that legacy SaaS will share AI-agent revenue with hyperscalers and CRM-style platforms; the rerating optionality is on whether Q1 FY27's traction proves durable.

§ 08 — Valuation

The math, line by line

Key assumptions — base case derivation

Variable	Formula · inputs · arithmetic	Base value
FY27 Revenue	FY26 actual × (1 + cons. growth) · $9.552B × 1.116	$10.66B
FY27 EBITDA	Revenue × cons. EBITDA margin · $10.66B × 24.6%	$2.62B
FY27 EPS (non-GAAP)	FMP 24-analyst consensus average	$10.58
Forward P/E multiple	Peer median 15.9x × 0% premium (WDAY +1pp vs peers; offset franchise risk)	15.5x
Forward EV/EBITDA	Peer mean 10.4x × ~35% franchise premium (WDAY GAAP EBITDA absorbs $1.6B SBC)	14.0x
WACC (CAPM)	(E/V × CoE) + (D/V × CoD × 1-T) · CoE = 1.04×5.0% + 4.30% = 9.50% · D/V 6.4% × 5.2% × 0.67	9.10%
Terminal growth	Long-run GDP 2.0% + enterprise-SaaS premium 0.5%	2.5%
Diluted shares (FY27)	Latest 10-Q diluted · 263.4M; FY27 buybacks ~$1.5B at $135 avg	252M

Bull / Base / Bear flex bridge

Variable	BEAR	Bear: why	BASE	BULL	Bull: why
FY27 Revenue	$10.40B	Fed/SLED/healthcare elongation extends through 2H	$10.66B	$11.00B	Q1 FY27 reaccel sustains; agentic attach upsides
FY27 EBITDA mgn	23.0%	AI investment outpaces revenue acceleration	24.6%	26.5%	Sana / Paradox margin accretion + restructuring lap
FY27 EPS	$9.50	Margin compression flows through	$10.58	$11.75	Rev + margin upside compound; buyback drives EPS
Fwd P/E	12.0x	Multiple re-tests March '26 low; agent rev treated as one-time	15.5x	18.0x	Re-rates to peer median; agent rev counted recurring
Fwd EV/EBITDA	11.0x	Re-tests CRM cluster floor	14.0x	17.0x	Re-rates closer to ADP / NOW mid-cycle
WACC	9.80%	Equity risk premium re-expands on tech derisking	9.10%	8.40%	Risk premium compresses with rate cuts; beta to 0.9
Terminal growth	2.0%	Long-run GDP only; no sector premium	2.5%	3.0%	GDP + ~1pp software premium

§ 09 — Valuation · Methodology + Scale

Blended fair value

Method	Bear	Base	Bull	Weight
Forward P/E	$114	$164	$212	40%
Forward EV/EBITDA	$94	$130	$175	40%
DCF (CAPM-WACC, 5Y FCF + TV)	$130	$185	$232	20%
Blended fair value	$109	$155	$201	100%

$128.14SPOT$109BEAR-15%$155BASE+21%12M TARGET$201BULL+57%

Forward P/E and EV/EBITDA apply each scenario's multiple to that scenario's FY27 consensus inputs. DCF is a 5-year explicit FCF path on the scenario's revenue growth and FCF margin assumption, discounted at scenario WACC, terminal-grown at the scenario's perpetuity rate. The 40/40/20 blend leans on multiples (cleaner cross-check) with DCF as a long-duration anchor. FMP's reference DCF prints $185 (5Y explicit forecast at 8.5% WACC, 2.5% terminal). Sell-side consensus PT is $184 (median $181); our $162 12-month target reflects the base-FV blend of $155 plus a small premium for forward-rotation as consensus FY28 EPS of $12.49 rolls in.

§ 10 — The Range · 12-Month View

Three cases, one call

BEAR · 25%

$109

-15% vs spot

FY27 sub rev $10.4B, op margin 23%, EPS $9.50. Multiple re-tests March 2026 low at 12x forward P/E. Federal pipeline materially slower through 2H. Q2 FY27 cRPO disappoints. Agentic ARR called 'lumpy' and excluded from durable revenue.

BASE · 50%

$155

+21% vs spot

FY27 sub rev $10.66B (consensus), op margin 30.5% (raised guide), EPS $10.58. Multiple rerates to 15.5x — back toward CRM territory. Agentic ARR confirmed +200% YoY at September analyst day. Q2 FY27 cRPO holds +15%. FY28 prelim guide ~14%.

BULL · 25%

$201

+57% vs spot

FY27 sub rev $11.0B (+200bps to consensus), op margin 26.5% (FY28 35% target pulled forward), EPS $11.75. Multiple expands to 18x as 'best Q1 in 5 years' becomes 'best FY in 5 years.' Organic agent ACV breaks out at the September analyst day.

BUY — 12-month price target $162

We initiate Workday at BUY with a $162 twelve-month price target, implying +26% total return from $128.14. Our blend at 40% P/E / 40% EV/EBITDA / 20% DCF produces a base fair value of $155; the additional ~5% reflects forward-rotation as consensus FY28 EPS of $12.49 enters the picture through 2H of 2026. The trade is asymmetric: $92 of upside to the bull case ($201) against $19 of downside to the bear ($109). The catalyst path is well-defined — Q2 FY27 print (Aug), Sep analyst day with agentic ARR disclosure, and FY28 prelim guide at the Feb 2027 Q4 print. We are most exposed to AI-agent execution risk; a missed Q2 cRPO would invalidate the relief-rally interpretation.

§ 11 — Risks & Catalysts

What breaks the thesis, what triggers the move

Six principal risks

AI-agent seat cannibalisation

HIGH

Salesforce Agentforce, OpenAI Operators, Microsoft Copilot, and start-ups all targeting HR/Fins automation; could compress seat counts even if Workday retains system-of-record.

Q2 FY27 cRPO miss

HIGH

Q1 FY27 reaccel could be one-quarter pull-forward of Q4 FY26 slippage. Q2 cRPO of <+13% would re-open the de-rating debate.

Federal / SLED pipeline drag

MED

Government IT funding pressure flagged by Rob Enslin in Q4 FY26; full-year impact on net-new ACV uncertain.

Margin reset further

MED

Aneel's de-prioritisation of the 35% FY28 op-margin target is open-ended; if FY27 invest yields no agentic upside, margins de-rate further.

CFO transition risk

LOW

Zane Rowe holding CFO; tenure stable. No imminent transition expected.

Consumption-pricing accounting

LOW

Flex Credits revenue recognition shift could create disclosure noise but is structurally bullish (transaction volumes ramping).

Four near-term catalysts

Q2 FY27 print + cRPO update (Aug 2026) — must hold ≥+15% YoY to confirm Q1 wasn't a one-quarter pull-forward; biggest single near-term gate.
September Analyst Day — first formal disclosure of agentic ARR run-rate and Flex Credits consumption metrics; bull-case scenarios live here.
Workday Rising 2026 (Sep, Las Vegas) — annual customer conference; product roadmap, organic-agent demos, system-of-record agent unveils.
FY28 preliminary guide (Feb 2027 Q4 print) — anything above +13% subscription growth signals AI is adding bookings rather than just compressing seats.

Faircurve Equities · Independent Single-Name Research · WDAY · 23 May 2026 · Issue No. 012

Sources: Financial Modeling Prep (quotes, statements, key metrics, analyst estimates, transcripts, price history). 8 quarterly earnings call transcripts (Q2 FY25 through Q1 FY27). Workday SEC filings (10-K FY26, 10-Q Q1 FY27).

Methodology: Forward FY+1 peer comparison. Consensus-anchored base case. 40/40/20 blend of Forward P/E, Forward EV/EBITDA, and CAPM-WACC DCF. Bull/Bear flex documented per variable.

Disclaimer: Research, not investment advice. Author has no position in WDAY at publication.